Vaidya Sane Ayurved Laboratories Limited IPO (Madhavbaug IPO)

Vaidya Sane Ayurved Laboratories Limited IPO Review

Madhavbaug is a medical service facility that combines contemporary technology with ancient Ayurvedic procedures to treat chronic conditions such as heart disease, diabetes, hypertension, and obesity. It treats chronic illnesses with non-invasive, interdisciplinary, and innovative therapy. The firm primarily treats health illness reversal, (ii) diabetes reversal, (iii) blood pressure control, (iv) obesity management, and (v) knee pain alleviation.

The firm maintains 274 clinics across Maharashtra, Madhya Pradesh, Gujarat, Uttar Pradesh, Goa, Karnataka, Delhi, and Chhattisgarh as of November 30, 2021. There are 52 company-owned clinics and 222 franchise clinics among these. In addition, the organisation has two cardiac preventive and rehabilitation facilities in Khopoli and Nagpur.

Subscription Dates

10 – 15 February 2022

Price Band

INR 73 per share

Fresh issue

27,71,200 shares (INR 20.23 crore)

Offer For Sale

Nil

Total IPO size

27,71,200 shares (INR 20.23 crore)

Minimum bid (lot size)

1,600 shares

Face Value 

INR10 per share

Retail Allocation

50%

Listing On

NSE Emerge

 

FY2019

FY2020

Revenue

62.57

75.30

Expenses

59.53

72.58

Net income

0.50

(0.56)

 

 

FY2021

H1 FY2022

Revenue

52.28

31.57

Expenses

47.65

28.95

Net income

1.55

1.35

Earnings Per Share (EPS): INR 2.22

Pre-IPO Price/Earnings (PE ratio): 32.91

Return on Net Worth (RONW): 15.84%

Net Asset Value (NAV): INR15.95 per share

Listing Performance of Vaidya Sane Ayurved Laboratories Limited IPO

Listed On : Feb 23, 2022

Issue Price : ₹73 per equity share

Listing Day Close : Feb 15, 2022

Listing Day Gain :

NSE : NA

ISIN CODE : INE0JR301013 

BSE : NA

IPO Open DateFeb 10, 2022
IPO Close DateFeb 15, 2022
Basis of Allotment DateFeb 18, 2022
Initiation of RefundsFeb 21, 2022
Credit of Shares to Demat AccountFeb 22, 2022
IPO Listing DateFeb 23, 2022

Vaidya Sane Ayurved Laboratories Limited
201 B, Bhoomi Velocity,
Road No. 23, Above ICICI Bank,
Wagle Estate, Thane (West),
Thane – 400604, Maharashtra
Phone: +91 7738070019
Email: cs@madhavbaug.com
Website: www.madhavbaug.org

Bigshare Services Private Limited
1st Floor, Bharat Tin Works Building,
Opp. Vasant Oasis,
Makwana Road, Marol,
Andheri East, Mumbai – 400 059,
Maharashtra, India
Phone: +91 22 6263 8200
Fax. No.: +91 22 6263 8299
Email: ipo@bigshareonline.com
Website: www.bigshareonline.com

Vaidya Sane Ayurved Laboratories Limited IPO FAQ's

The Vaidya Sane Ayurved Laboratories Limited IPO is a NSE SME IPO of ₹125 per equity share with a face value of 10 per equity share. 

The issue size is priced at 2,771,200 Eq Shares of ₹10 (aggregating up to ₹20.23 Cr). The fresh issue size priced at 2,771,200 Eq Shares of ₹10 (aggregating up to ₹20.23 Cr).

The initial public offering (IPO) begins on Feb 10, 2022 and ends on Feb 15, 2022.

The registrar for the IPO is Link Intime India Private Ltd. The shares are proposed for listing on the NSE and SME.

The Vaidya Sane Ayurved Laboratories Limited IPO opens on Feb 10, 2022 and closes on Feb 15, 2022. The IPO Issue date may list on Feb 23, 2022.

Vaidya Sane Ayurved Laboratories Limited IPO Market lot size is 1600 Shares and the minimum order quantity is 1600 Shares.

The finalisation of Basis of Allotment for Vaidya Sane Ayurved Laboratories Limited IPO will be done on Feb 18, 2022. and the allotted shares will be credited to your demat account by Feb 22, 2022. Check the Vaidya Sane Ayurved Laboratories Limited IPO status.

The Vaidya Sane Ayurved Laboratories Limited IPO listing date is on Feb 23, 2022.

Vaidya Sane Ayurved Laboratories Limited IPO applications can be submitted online using either UPI or ASBA as a payment method. The ASBA IPO application is available in your bank’s net banking. Brokers who do not provide banking services provide UPI IPO applications. Learn more about online IPO applications from Zerodha, Upstox, 5Paisa, Edelweiss, ICICI Bank, HDFC Bank, and SBI Bank.

Vaidya Sane Ayurved Laboratories Limited IPO Comments